Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are not predictive of pathologic complete response to neoadjuvant chemotherapy in triple-negative breast cancer

Pinho, I. Soares deBarroso, T.Trabulo, C.Campoa, E.Patel, V.Gonçalves, L.Araújo, J.Monteiro, C.Ferreira, A.Machado, B.Dâmaso, S.Luz, P.Sousa, R. Teixeira deCosta, L.2025-03-102025-03-102023-040960-9776http://hdl.handle.net/10400.1/26881Pathological complete response (pCR) to neoadjuvant chemotherapy (NAChT) has been validated as a predictor of long-term survival in breast cancer (BC), especially in triple-negative breast cancer (TNBC)engNeutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are not predictive of pathologic complete response to neoadjuvant chemotherapy in triple-negative breast cancerconference object10.1016/s0960-9776(23)00276-x